The role of patients organizations in funding and managing R&D for rare disease

Frederic Revah Ph.D., CEO, Genethon, joined us last year at the World ted in finding out more about pricing and reimbursement, then join us at the 15th Annual World Orphan DrugCongress Europe to present on ‘The role of patients organizations in funding and managing R&D for rare disease.’